News Release

Iga City, Mie Prefecture x Rohto Pharmaceutical Co., Ltd. conduct a pilot educational program to prevent myopia in children.

Focusing on CMC damage inside the hair caused by sunlight, potassium hyaluronate was confirmed to have an effect in suppressing "frizz recurrence."

Rohto has discovered that its unique milk peptide ingredient acts not only on bones and blood, but also on growing muscles!

Rohto Pharmaceutical's "Mirumirunobiru" project has launched.

Rohto Pharmaceutical joins "ASAGI Labs Longevity Consortium"

Based on cell research, we will accelerate the social implementation of "longevity" science.

ROHTO Zi ® Slime eye drops are now King Slime eye drops! The third installment of this popular collaboration eye drop series is available in limited quantities!

Automated HPLC analysis sample preparation system for quality control is being developed for practical use.

Certified as an "Excellent Food Education Practice Corporation 2026" by the Ministry of Agriculture, Forestry and Fisheries.

Notice of Manufacturing and Marketing Approval Application for "ROH-101 (Ganciclovir Eye Drops Gel)," a Treatment for Cytomegalovirus Corneal Endotheliitis